Elevance Health (NYSE:ELV) Raised to “Buy” at Argus
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by Argus from a “hold” rating to a “buy” rating in a research note issued on Monday, Marketbeat Ratings reports. The brokerage currently has a $450.00 price target on the stock. Argus’ price objective indicates a potential upside of 3.14% from the stock’s previous close. ELV […]
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by Argus from a “hold” rating to a “buy” rating in a research note issued on Monday, Marketbeat Ratings reports. The brokerage currently has a $450.00 price target on the stock. Argus’ price objective indicates a potential upside of 3.14% from the stock’s previous close. ELV […]
